FDA Inspection 1303460 — Jonathan D. Harper, MD

Jonathan D. Harper, MD — FEI 3041669486

The FDA completed an inspection of Jonathan D. Harper, MD on Feb 12, 2026 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 12, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Seattle, WA (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.